SS Innovations International (NASDAQ: SSII) has reported significant growth in the adoption and utilization of its SSi Mantra surgical robotic system, according to a recent press release. As of September 8, 2026, the company had logged 14,103 cumulative procedures, a 79% increase from 7,885 at the end of 2025. The installed base of systems grew 42% to 238 units, up from 168 at year-end 2025.
The SSi Mantra is now installed in 12 countries, and approximately 1,500 physicians have been trained on the platform. The system has been used for more than 170 types of surgical procedures. Recent international milestones include the launch of robotic cardiac surgery in Colombia, the first installation of an SSi Mantra in Sri Lanka, and the first telesurgery within the Philippines.
SS Innovations also highlighted 258 cumulative pediatric robotic surgeries and 188 robotic telesurgeries as of August 31, including a telesurgery spanning more than 13,600 miles between Colombia and India. In August, five SSi Mantra systems were used to complete 50 robotic general surgery procedures in a single day in India, demonstrating the system's capacity for high-volume surgical workflows.
Looking ahead, the company expects the U.S. Food and Drug Administration to complete its review of the SSi Mantra 510(k) premarket notification by the end of the first quarter of 2027. Additionally, SS Innovations believes European Union CE marking certification can be obtained by year-end 2026. These regulatory milestones are critical for expanding into two of the world's largest healthcare markets.
For leaders in healthcare and technology, this growth signals a broader trend: robotic surgery is moving from niche to mainstream, driven by systems that prioritize affordability and accessibility. SS Innovations, an American company headquartered in India, aims to make robotic surgery affordable and accessible to a larger segment of the global population. Its product range includes the SSi Mantra system and the SSi Mudra suite of surgical instruments, which support a variety of procedures including cardiac surgery.
The company's progress in telesurgery and pediatric applications also points to the expanding use cases for robotic systems, potentially improving surgical outcomes in remote or underserved regions. The 13,600-mile telesurgery between Colombia and India exemplifies how robotic technology can bridge geographical gaps in surgical expertise.
The full report is available at https://ibn.fm/DJILj. The latest news and updates relating to SSII are available in the company's newsroom at https://ibn.fm/SSII. For terms of use and disclaimers, visit https://IBN.ai/Disclaimer.
